James Engelhart

Overview

James Engelhart received an average of $2M in total compensation, including $310K in salary, at Biohaven Pharmaceutical Holding Co Ltd. from 2016 to 2018.

Source: SEC filings on April 11, 2019 and March 29, 2018.

Related executives

We found four more executives who work or worked at Biohaven Pharmaceutical Holding Co Ltd..

Vlad Coric

Biohaven Pharmaceutical Holding Co Ltd.

Chief Executive Officer

Charles Conway

Biohaven Pharmaceutical Holding Co Ltd.

Chief Scientific Officer

Kimberly Gentile

Biohaven Pharmaceutical Holding Co Ltd.

SVP, Clinical Operations

John Tilton

Biohaven Pharmaceutical Holding Co Ltd.

Chief Commercial Officer

News

You may also like